# A Trial of Rivaroxaban Versus Warfarin in Dissolving Left Atrial Appendage Thrombus in Patients With Atrial Fibrillation

> **NCT03792152** · NA · UNKNOWN · sponsor: **The Second Affiliated Hospital of Chongqing Medical University** · enrollment: 80 (estimated)

## Conditions studied

- Atrial Fibrillation
- Left Atrial Appendage Thrombosis
- Rivaroxaban

## Interventions

- **DRUG:** Rivaroxaban
- **DRUG:** Warfarin

## Key facts

- **NCT ID:** NCT03792152
- **Lead sponsor:** The Second Affiliated Hospital of Chongqing Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-06-01
- **Primary completion:** 2022-01-01
- **Final completion:** 2022-12-30
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2019-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03792152

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03792152, "A Trial of Rivaroxaban Versus Warfarin in Dissolving Left Atrial Appendage Thrombus in Patients With Atrial Fibrillation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03792152. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*